View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Thermo Fisher Scientific Inc: 1 director

A director at Thermo Fisher Scientific Inc sold 9,000 shares at 552.863USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Thermo Fisher Scientific Inc.: Update following outlook change to posi...

Our credit view of this issuer reflects its significant scale and good diversification, constrained by its appetite for large acquisitions and shareholder-friendly financial policies

Thermo Fisher Scientific Inc.: Key facts and statistics - 2023

A summary company profile, detailing Thermo Fisher’s business operations and financial highlights.

Moody's assigns A3 rating to Thermo Fisher's CHF notes; outlook stable

Moody's Investors Service ("Moody's") assigned an A3 rating to the new CHF-denominated senior unsecured notes offering by Thermo Fisher Scientific Inc. ("Thermo Fisher"). There are no changes to Thermo Fisher's existing ratings including the A3 senior unsecured long-term ratings and the Prime-2 seni...

Moody's assigns A3 rating to Thermo Fisher's new senior unsecured note...

Moody's Investors Service ("Moody's") assigned an A3 rating to the new senior unsecured notes offering by Thermo Fisher Scientific Inc. ("Thermo Fisher"). There are no changes to Thermo Fisher's existing ratings including the A3 senior unsecured long-term ratings and the senior unsecured commercial ...

Thermo Fisher Scientific Inc.: Good ability to weather near-term headw...

Our credit view of this issuer reflects its strong organic growth prospects, constrained by its shareholder-friendly financial policies including share buybacks and dividends.

Moody's assigns A3 rating to Thermo Fisher's new senior unsecured note...

Moody's Investors Service ("Moody's") assigned an A3 rating to the new senior unsecured notes offering by Thermo Fisher Scientific Inc. ("Thermo Fisher"). There are no changes to Thermo Fisher's existing ratings including the A3 senior unsecured long-term rating and the Prime-2 short-term rating. Th...

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

Global CDMOs - Overcapacity is Coming (Thematic Research)

We have calculated the significant supply about to enter the biologics manufacturing space & analysed demand growth. Whilst the market assumes an improvement in utilisation from 2024, we forecast there will be significant overcapacity in the coming years resulting in even lower utilisation at an industry level. Our detailed bottom-up analysis shows that total mammalian cell supply is set to grow by 11% p.a. 2023-26 but demand is set to grow just 8% p.a. over the same period. However, much more c...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Thermo Fisher Scientific Inc.: Key facts and statistics - 2022

A summary company profile, detailing Thermo Fisher Scientific Inc.’s business operations and financial highlights.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch